← Back
$APRE All transactions

Aprea Therapeutics, Inc.

A

$ Value

$0

Shares

4,185

Price

$0

Filed

Jun 9

Insider

Name

BIZZARI JEAN-PIERRE

Title

CIK

0001630914

Roles

Director

Transaction Details

Transaction Date

2025-06-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,185

Footnotes

These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions. | The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Filing Info

Accession No.

0001104659-25-057806

Form Type

4

Issuer CIK

0001781983

BIZZARI JEAN-PIERRE's History

Date Ticker Type Value
2025-06-13 ADCT F $45K
2025-06-05 APRE A $0
2025-06-05 APRE A $0
2025-06-03 ADCT A $0

Other Insiders at APRE (90d)

Insider Bought Sold Last
Peters Richard $100K 2026-03-31
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
$30K 2026-03-31
Gilad Oren
President/CEO
$25K 2026-03-12